With global cases of COVID-19 surpassing four million, researchers are continuing to learn more about the virus, and trying to find ways to treat it.  The SARS-Cov-2 coronavirus that causes COVID-19 uses the angiotensin-converting enzyme 2 (ACE2) receptor to gain entry to host cells.  At MSU, a collaboration has begun among the labs of Bruce Uhal, Yong-Hui Zheng, and the MSU Drug Discovery group to further understand the entry mechanism and to discover methods to block the virus and host cell interaction.

See more on Dr. Thomas Dexheimer